H&P/Triad OTC Manufacturing Woes Lead To $6M FDA Seizure
This article was originally published in The Tan Sheet
Executive Summary
At FDA's request, the U.S. Marshals Service seized OTC drug products from sister companies that had multiple run-ins with the agency since 2009 – Triad Group and H&P Industries.
You may also be interested in...
Recall Survival: Fast, Detailed Communication Can Save A Brand
Manufacturers should be prepared before a recall, with designated spokespeople and a dedicated website that can launch quickly, experts advised during a CHPA webinar. Firms should make clear, first and foremost, that they care about their consumers’ safety.
Recall Survival: Fast, Detailed Communication Can Save A Brand
Manufacturers should be prepared before a recall, with designated spokespeople and a dedicated website that can launch quickly, experts advised during a CHPA webinar. Firms should make clear, first and foremost, that they care about their consumers’ safety.
H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.